Interleukin-10 antibodies

Details Interleukin-10 antibodies Interleukin-10 antibodies

2007-01-12

2010-02-16

Shukla, Ram R (Department: 1644)

Drug, bio-affecting and body treating compositions

Immunoglobulin, antiserum, antibody, or antibody fragment,...

Structurally-modified antibody, immunoglobulin, or fragment...

C424S145100, C530S387300, C530S388230

Reexamination Certificate

active

07662379

ABSTRACT:
The methods and compositions provided herein relate generally to IL-10 specific antibodies and uses thereof. More specifically, the methods and compositions provided herein relate to humanized IL-10 specific antibodies and methods to use such antibodies in modulating the biological activity of IL-10, particularly in autoimmune disorders and pathogen-mediated immunopathology.

REFERENCES:
patent: 5585089 (1996-12-01), Queen et al.
patent: 6407213 (2002-06-01), Carter et al.
patent: 2002/0039581 (2002-04-01), Carreno et al.
patent: 2003/0039649 (2003-02-01), Foote
patent: 2003/0108966 (2003-06-01), Mather
patent: 0 541 214 (1993-05-01), None
patent: WO 94/04180 (1994-03-01), None
patent: WO 02/46237 (2002-06-01), None
patent: WO 03/085089 (2003-10-01), None
Portolano et al., J Immunol. Feb. 1, 1993 ;150(3):880-7.
Lin et al., Infect Immun. Apr. 1996;64(4):1351-6.
Heinrichs et al., J Immunol Methods. Jan. 27, 1995;178(2):241-51.
Schroeder et al., Proc Natl Acad Sci U.S.A. Aug. 1990; 87(16):6146-50.
Abrams et al.Immunol rev.Jun. 1992; 127:5-24 “Strategies of Anti-Cytokine Monoclonal Antibody Development: Immunoassay of IL-10 and IL-5 in Clinical Samples”.
Beebe et al.Cytokine&Growth Factor Reviews(2002) 13:403-412 “The role of interleukin-10 in autoimmune desease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS)”.
Brady et al.Eur. J. Immunol.(2003) 33:3448-3457 “Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes”.
Caldas et al.,Molecular Immunol.(2003) 39:941-952 “Humanization of the anti-CD18 antibody 6.7: an unexpected effect of a framework residue in binding to antigen”.
Caldas et al.,Protein Engineering(2000) 13(5):353-360 “Design and synthesis of germline-based hemi-humanized single-chain Fv against the CD18 surface antigen”.
Clerici et al.,J. Clin. Invest.(Feb. 1994) 93:768-775 “Role of Interleukin-10 in T Helper Cell Dysfunction in Asymptomatic Individuals Infected with the Human Immunodeficiency Virus”.
D'Andrea et al.,J. Exp. Med.(1993) 178:1041-1048 “Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon γ -Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells”.
De Waal Malefyt et al.,J. Exp. Med.(1991) 174:915-924 “Interleukin 10 (IL-10) and Viral IL-10 Strongly Reduce Antigen-specific Human T Cell Proliferation by Diminishing the Antigen-presenting Capacity of Monocytes via Downregulation of Class II Major Histocompatibility Complex Expression”.
Fiorentino et al.,J. Exp. Med.(1989) 170:2081-2095 “Two Types of Mouse T Helper Cell, IV. Th2 Clones Secrete a Factor that Inhibits Cytokine Production by Th1 Clones”.
Fiorentino et al.,J. Immunol.(1991) 146:3444-3451 “IL-10 Acts on the Antigen-Presenting Cell to Inhibit Cytokine Production by Th1 Cells”.
Fiorentino et al.,J. Immunol.(1991) 147:3815-3822 ,“IL-10 Inhibits Cytokine Production by Activated Macrophages”.
Gonzalez-Amaro, et al.J. Autoimmunity(1998) 11:395-402 “Role of IL-10 in the Abnormalities of Early Cell Activation Events of Lymphocytes from Patients with Systemic Lupus Erythematosus”.
Hsu et al.,Int. Immunol.(1992) 4:563-569 “Differential effects of IL-4 and IL-10 on IL-2-induced IFN-γ synthesis and lymphokine-activated killer activity”.
Huang, et al.,Mol. Immunol.(1997) 34(18):1291-1301 “Variable Domain Structure of κIV Human Ligth Chain Len: High Homology to the Murine Light Chain McPC603”.
Illei and CzirjákExpert Opin. Investig. Drugs(2001) 10(6):1117-1130 “Novel Approaches in the Treatment of Lupus Nephritis”.
Ishida, H.,Medical Immunology(1991) 21(5):625-629, Japanese Publication (English Translation), “Interleukin 10”.
Janeway et al.Immunobiology,5thEd., Garland Science, pp. 100-105 (2001.).
Llorente et al.Arthritis Rheum.Aug. 2000;43(8):1790-800 “Clinical and Biologic Effects of Anti-Interleukin-10 Monoclonal Antibody Administration in Systemic Lupus Erythematosus”.
Ma, Xiaojing, et al. (2000)J. of Immunol.164(4):1722-1729 “Inhibition of IL-12 production in human monocyte-derived macrophages by TNF”.
Moore et al.,Annu. Rev. Immunol.(1993) 11:165-190 “Interleukin-10”.
Pavlinkova et al.,Cancer Immunol. Immunother.(2000) 49:267-275 “Pharmacokinetics and biodistribution of a light-chain-shuffled CC49 single-chain Fv antibody construct”.
Pluschke et al.,J. Immunol. Methods(1998) 215:27-37 “Generation of chimeric monoclonal antibodies from mice that carry human immunoglobulin Cγ1 heavy of Cκ light chain gene segments”.
Takai et al.Int. Arch. Allergy Immunol.(2000) 123:308-318 “Inhibition of IgE-Dependent Histamine Release from Human Peripheral Blood Basophils by Humanized Fab Fragments That Recognize the Membrane Proximal Domain of the Human Fcε RI α-Chain”.
Tan et al.J. Immunology(2002) 169:1119-1125 ““Superhumanized” Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD28”.
Wu et al.,J. Mol. Biol.(1999) 294:151-162 “Humanization of a Murine Monoclonal Antibody by Simultaneous Optimization of Framework and CDR Residues”.
Hudson, et al. (2003)Nature Medicine9(1):129-134 “Engineered Antibodies”.
Merluzzi, et al. (2000)Advances in Clinical Pathology4(2):77-85 “Humanized antibodies as potential drugs for therapeutic use”.

Affiliated with

Also associated with

Rating

Interleukin-10 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Interleukin-10 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Interleukin-10 antibodies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4198686